Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162,190,120
-
Number of holders
-
399
-
Total 13F shares, excl. options
-
33,397,602
-
Shares change
-
-3,998,999
-
Total reported value, excl. options
-
$4,783,479,130
-
Value change
-
-$707,719,453
-
Put/Call ratio
-
197%
-
Number of buys
-
174
-
Number of sells
-
-220
-
Price
-
$143.07
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q4 2021
532 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q4 2021.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 399 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33,397,602 shares
of 162,190,120 outstanding shares and own 20.59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6,897,007 shares), BlackRock Inc. (4,395,161 shares), RA CAPITAL MANAGEMENT, L.P. (2,097,794 shares), STATE STREET CORP (1,899,220 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,264,172 shares), HSBC HOLDINGS PLC (1,010,246 shares), GEODE CAPITAL MANAGEMENT, LLC (983,170 shares), MORGAN STANLEY (956,492 shares), Capital World Investors (875,148 shares), and JANE STREET GROUP, LLC (649,790 shares).
This table shows the top 399 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.